Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators

Konstantinos Tsiakos, Antonios Tsakiris, Georgios Tsibris, Pantazis Voutsinas, Periklis Panagopoulos, Maria Kosmidou, Vasileios Petrakis, Areti Gravvani, Theologia Gkavogianni, Eleftherios Klouras, Konstantina Katrini, Panagiotis Koufargyris, Iro Rapti, Athanassios Karageorgos, Emmanouil Vrentzos, Christina Damoulari, Vagia Zarkada, Chrysanthi Sidiropoulou, Sofia Artemi, Androniki Papapostolou, Evangelos Michelakis, Maria Georgiopoulou, Dimitra-Melia Myrodia, Panteleimon Tsiamalos, Konstantinos Syrigos, George Chrysos, Thomas Nitsotolis, Haralampos Milionis, Garyphallia Poulakou, Evangelos J. Giamarellos-Bourboulis
doi: https://doi.org/10.1101/2020.12.22.20248753

Data Availability

Date are available from the corresponding author on request.

Back to top
Posted December 26, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators
Konstantinos Tsiakos, Antonios Tsakiris, Georgios Tsibris, Pantazis Voutsinas, Periklis Panagopoulos, Maria Kosmidou, Vasileios Petrakis, Areti Gravvani, Theologia Gkavogianni, Eleftherios Klouras, Konstantina Katrini, Panagiotis Koufargyris, Iro Rapti, Athanassios Karageorgos, Emmanouil Vrentzos, Christina Damoulari, Vagia Zarkada, Chrysanthi Sidiropoulou, Sofia Artemi, Androniki Papapostolou, Evangelos Michelakis, Maria Georgiopoulou, Dimitra-Melia Myrodia, Panteleimon Tsiamalos, Konstantinos Syrigos, George Chrysos, Thomas Nitsotolis, Haralampos Milionis, Garyphallia Poulakou, Evangelos J. Giamarellos-Bourboulis
medRxiv 2020.12.22.20248753; doi: https://doi.org/10.1101/2020.12.22.20248753
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area